Transforming growth factor‐β1‐dependent activation of Smad2/3 and up‐regulation of PAI‐1 expression is negatively regulated by Src in SKOV‐3 human ovarian cancer cells
- 20 July 2004
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 93 (3) , 437-453
- https://doi.org/10.1002/jcb.20160
Abstract
The net balance between urokinase‐type plasminogen activator (uPA) and plasminogen activator inhibitor type‐1 (PAI‐1) has been implicated in tumor cell invasion and metastasis. To elucidate the mechanism of the transforming growth factor‐β1 (TGF‐β1)‐dependent up‐regulation of PAI‐1 expression, we investigated which signaling pathway transduced by TGF‐β1 is responsible for this effect. Here, we show (1) nontoxic concentrations of TGF‐β1 up‐regulates uPA expression in HRA and SKOV‐3 human ovarian cancer cells, (2) TGF‐β1 activates Smads (phosphorylation of Smad2 and nuclear translocation of Smad3) and subsequently up‐regulates PAI‐1 expression in HRA cells, whereas TGF‐β1 neither activates Smads nor up‐regulates PAI‐1 in SKOV‐3 cells, (3) pharmacological Src inhibitor PP2 or antisense (AS) c‐Src oligodeoxynucleotide (ODN) treatment significantly induces TGF‐β1‐dependent activation of Smads, leading to PAI‐1 synthesis, compared with controls, in SKOV‐3 cells, (4) combination of TGF‐β1 and PP2, which activates PAI‐1 expression and reduces uPA expression in SKOV‐3, results in decreased invasiveness, (5) pharmacological inhibitors for mitogen‐activated protein kinase (MAPK) (PD98059) and phosphoinositide‐3‐kinase (PI3K) (LY294002 and wortmannin) or AS‐PI3K ODN transfection do not affect TGF‐β1‐induced Smad signaling and up‐regulation of PAI‐1 expression in SKOV‐3 cells pretreated with PP2, and (6) the induction of PAI‐1 protein was partially inhibited by an inhibitor of Sp1‐DNA binding, mithramycin, implicating, at least in part, Sp1 in the regulation of this gene by TGF‐β1. In conclusion, TGF‐β1‐dependent activation of Smad2/3, leading to PAI‐1 synthesis, may be negatively regulated by Src, but not its downstream targets MAPK and PI3K in SKOV‐3 cells. These data also reflect the complex biological effect of uPA‐PAI‐1 system.Keywords
This publication has 36 references indexed in Scilit:
- Transforming Growth Factor-β-induced Apoptosis Is Mediated by Smad-dependent Expression of GADD45b through p38 ActivationJournal of Biological Chemistry, 2003
- A Kunitz-type Protease Inhibitor, Bikunin, Inhibits Ovarian Cancer Cell Invasion by Blocking the Calcium-dependent Transforming Growth Factor-β1 Signaling CascadeJournal of Biological Chemistry, 2003
- Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikuninInternational Journal of Cancer, 2003
- Involvement of Cell-Cell Interactions in the Rapid Stimulation of Cas Tyrosine Phosphorylation and Src Kinase Activity by Transforming Growth Factor-β1Published by Elsevier ,2002
- Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumoursExpert Opinion on Biological Therapy, 2001
- Divergence and convergence of TGF‐β/BMP signalingJournal of Cellular Physiology, 2001
- Molecular mechanisms of TGF‐β antagonism by interferon γ and cyclosporine A in lung fibroblastsThe FASEB Journal, 2001
- Suppression of Urokinase Expression and Invasiveness by Urinary Trypsin Inhibitor Is Mediated through Inhibition of Protein Kinase C- and MEK/ERK/c-Jun-dependent Signaling PathwaysPublished by Elsevier ,2001
- TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997
- Partnership between DPC4 and SMAD proteins in TGF-β signalling pathwaysNature, 1996